Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Algeron vs PegIntron in HCV/HIV Coinfection
NCT02103439Phase 3Completed
- Sponsor
- BIOCAD
- Start
- Jun 2013
- Primary completion
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of ropeginterferon alfa-2b in hepatitis C (HCV), sponsored by BIOCAD. Started Jun 2013; status: completed.
02
Drugs
ropeginterferon alfa-2b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02103439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02103439.